Groowe Groowe / Newsroom / MOLN
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

MOLN News

Molecular Partners AG American Depositary Shares

Molecular Partners Reports H1 2026 Financial Results and Corporate Highlights: DLL3 Radiotherapy MP0712 Successfully Advancing to Higher Dose Level in Phase 1/2a Study

globenewswire.com
MOLN

Molecular Partners Announces Clinical Progress in Phase 2 TACTIC Combination Trial of MP0317 for Patients with Cholangiocarcinoma

globenewswire.com
MOLN

Molecular Partners Showcases Bispecific Radio-DARPins at Gordon Research Conference

globenewswire.com
MOLN

Molecular Partners Updates on Clinical Progress Across Expanding Pipeline of DARPin Radiotherapeutics

globenewswire.com
MOLN

Molecular Partners and Orano Med Announce First Patients Dosed in Phase 1/2a Trial of DLL3 Radio-DARPin MP0712

globenewswire.com
MOLN

Molecular Partners Holds Presentations at ASCO and SNMMI 2026 on DLL3-Targeting Radio-DARPin MP0712, Now Dosing Patients in Phase 1

globenewswire.com
MOLN

Synovial Sarcoma Clinical Trial Pipeline Accelerates as 15+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

globenewswire.com
KURA BMY IPHA MRK MNPR JAZZ MOLN LLY GSK AGEN PFE

Molecular Partners to Present at TD Cowen’s 7th Annual Oncology Innovation Summit

globenewswire.com
MOLN

The Inner Circle acknowledges Ilene Fennoy, MD, MPH as a Pinnacle Professional Member Inner Circle of Excellence

prnewswire.com
COLB SNY BMY PFE MRK JNJ ABBV GILD AMGN REGN BIIB CRSP VRTX MDLZ KHC PEP KO SBUX MCD YUM CMG TSLA NVDA GOOG MSFT AMZN META IBM ORCL CSCO ADBE CRM INTC AMD QCOM MU SMCI ACN NOW PANW SNPS CDNS MRVL LRCX KLAC ASML AMAT NXPI ON INFY WMT COST HD LOW TGT BBY MGM LVS WYNN MAR HPE HPQ DELL XRX GE BA LMT RTX GD NOC CAT DE HON MMM AXP V MA JPM BAC WFC GS MS DIS CMCSA NFLX T VZ CHTR TMUS XOM CVX SHEL BABA JD PDD NTES BIDU IQ BILI EDU RLX LI XPEV NIO CPT M KSS ROST TJX URBN PVH RL AEO ANF LULU UA NKE CROX EAT SJM GIS ADM IFF CPB KDP MNST STZ CCEP BUD MOLN CRBU EDIT NTLA BEAM ALNY AZN BNTX MRNA XBIT RBLX EXAS CRWD FTNT OKTA DDOG SNOW PLTR AI UPST PYPL COIN MARA CLSK RIOT BTBT MSTR

Molecular Partners Reports Financial Results and Highlights for Q1 2026, with Clinical Studies Initiated on MP0712 and MP0317

globenewswire.com
MOLN